Metropolitan Life Insurance CO Arcus Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

42 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$14.83 - $20.18 $6,302 - $8,576	-425 Reduced 12.9%	2,870 $54,000
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $9,056 - $12,099	514 Added 18.48%	3,295 $59,000
Q1 2023 May 15, 2023	SELL	$15.96 - $23.15 $5,713 - $8,287	-358 Reduced 11.4%	2,781 $50,000
Q4 2022 Jun 14, 2023	BUY	$19.7 - $35.71 $7,052 - $12,784	358 Added 12.87%	3,139 $64.9 Million
Q4 2022 Mar 30, 2023	BUY	$19.7 - $35.71 $2,817 - $5,106	143 Added 4.77%	3,139 $64,000
Q4 2022 Feb 15, 2023	BUY	$19.7 - $35.71 $2,817 - $5,106	143 Added 4.77%	3,139 $64,000
Q3 2022 Jun 14, 2023	BUY	$23.23 - $30.07 $4,994 - $6,465	215 Added 7.73%	2,996 $78.4 Million
Q2 2022 Jun 20, 2023	BUY	$17.23 - $37.73 $3,704 - $8,111	215 Added 7.73%	2,996 $75,000
Q1 2022 Jun 20, 2023	BUY	$28.92 - $41.83 $6,217 - $8,993	215 Added 7.73%	2,996 $94,000
Q1 2022 Mar 30, 2023	SELL	$28.92 - $41.83 $263,952 - $381,782	-9,127 Reduced 75.29%	2,996 $94,000
Q1 2022 May 12, 2022	SELL	$28.92 - $41.83 $263,952 - $381,782	-9,127 Reduced 75.29%	2,996 $95,000
Q4 2021 Jun 21, 2023	BUY	$31.38 - $48.47 $293,151 - $452,806	9,342 Added 335.92%	12,123 $490,000
Q3 2021 Jun 21, 2023	BUY	$26.93 - $37.68 $251,580 - $352,006	9,342 Added 335.92%	12,123 $422,000
Q2 2021 Jun 21, 2023	BUY	$22.75 - $35.77 $212,530 - $334,163	9,342 Added 335.92%	12,123 $332,000
Q2 2021 Mar 30, 2023	BUY	$22.75 - $35.77 $19,246 - $30,261	846 Added 7.5%	12,123 $332,000
Q2 2021 Aug 16, 2021	BUY	$22.75 - $35.77 $275,548 - $433,246	12,112 Added 110109.09%	12,123 $333,000
Q1 2021 Jun 26, 2023	BUY	$26.16 - $41.39 $222,255 - $351,649	8,496 Added 305.5%	11,277 $317 Million
Q1 2021 Mar 30, 2023	SELL	$26.16 - $41.39 $13,864 - $21,936	-530 Reduced 4.49%	11,277 $316,000
Q1 2021 May 14, 2021	SELL	$26.16 - $41.39 $308,583 - $488,236	-11,796 Reduced 99.91%	11 $317,000
Q4 2020 Jun 22, 2023	BUY	$17.0 - $32.36 $153,442 - $292,081	9,026 Added 324.56%	11,807 $306,000
Q3 2020 Jun 26, 2023	BUY	$17.14 - $25.47 $154,705 - $229,892	9,026 Added 324.56%	11,807 $202,000
Q3 2020 Mar 30, 2023	BUY	$17.14 - $25.47 $6,187 - $9,194	361 Added 3.15%	11,807 $202,000
Q3 2020 Nov 13, 2020	BUY	$17.14 - $25.47 $6,187 - $9,194	361 Added 3.15%	11,807 $202,000
Q2 2020 Jun 26, 2023	BUY	$13.97 - $36.56 $121,050 - $316,792	8,665 Added 311.58%	11,446 $283,000
Q2 2020 Mar 30, 2023	BUY	$13.97 - $36.56 $3,855 - $10,090	276 Added 2.47%	11,446 $283,000
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $3,855 - $10,090	276 Added 2.47%	11,446 $283,000
Q1 2020 Jul 12, 2023	BUY	$8.78 - $19.28 $73,655 - $161,739	8,389 Added 301.65%	11,170 $155,000
Q1 2020 Mar 30, 2023	BUY	$8.78 - $19.28 $11,018 - $24,196	1,255 Added 12.66%	11,170 $155,000
Q1 2020 May 15, 2020	BUY	$8.78 - $19.28 $11,018 - $24,196	1,255 Added 12.66%	11,170 $155,000
Q4 2019 Jul 12, 2023	BUY	$7.33 - $10.79 $52,292 - $76,975	7,134 Added 256.53%	9,915 $100,000
Q4 2019 Mar 30, 2023	SELL	$7.33 - $10.79 $11,955 - $17,598	-1,631 Reduced 14.13%	9,915 $100,000
Q4 2019 Feb 14, 2020	SELL	$7.33 - $10.79 $11,955 - $17,598	-1,631 Reduced 14.13%	9,915 $100,000
Q3 2019 Jul 12, 2023	BUY	$6.44 - $10.18 $56,446 - $89,227	8,765 Added 315.17%	11,546 $105,000
Q3 2019 Mar 30, 2023	BUY	$6.44 - $10.18 $9,151 - $14,465	1,421 Added 14.03%	11,546 $105,000
Q3 2019 Nov 14, 2019	BUY	$6.44 - $10.18 $9,151 - $14,465	1,421 Added 14.03%	11,546 $105,000
Q2 2019 Jul 12, 2023	BUY	$7.29 - $13.38 $63,896 - $117,275	8,765 Added 315.17%	11,546 $91,000
Q1 2019 Jul 13, 2023	BUY	$8.95 - $12.49 $65,728 - $91,726	7,344 Added 264.08%	10,125 $126,000
Q1 2019 Mar 30, 2023	BUY	$8.95 - $12.49 $62,524 - $87,255	6,986 Added 222.55%	10,125 $126,000
Q1 2019 May 16, 2019	SELL	$8.95 - $12.49 $127,412 - $177,807	-14,236 Reduced 58.44%	10,125 $126,000
Q1 2019 May 15, 2019	BUY	$8.95 - $12.49 $115,472 - $161,145	12,902 Added 112.59%	24,361 $61,000
Q4 2018 Jul 13, 2023	BUY	$9.74 - $14.5 $84,523 - $125,831	8,678 Added 312.05%	11,459 $123,000
Q4 2018 Feb 14, 2019	BUY	$9.74 - $14.5 $111,610 - $166,155	11,459 New	11,459 $123,000

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

Black Rock Inc. New York, NY

9.76M
Shares

$139 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.47M
Shares

$77.7 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

3.48M
Shares

$49.4 Million
0.48% of portfolio
State Street Corp Boston, MA

3.01M
Shares

$42.8 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.44M
Shares

$34.6 Million
0.1% of portfolio

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account